09/06/2021
EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
07/06/2021
07/06/2021
01/06/2021
31/05/2021
27/05/2021
27/05/2021
2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
26/05/2021
26/05/2021
25/05/2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
20/05/2021
20/05/2021
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
20/05/2021
19/05/2021
EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open
18/05/2021
EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
18/05/2021
EuropaBio is pleased to announce that Lallemand has joined the organization as a corporate member.
12/05/2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
12/05/2021
EuropaBio is pleased to announce that Meatable has joined the organization as an associate member.
12/05/2021
EuropaBio sat down with new Member Meatable, to find out about their journey from creation in 2018.
07/05/2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge
2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position